HPV-associated neuroendocrine carcinoma of the oropharynx: A rare new entity with potentially aggressive clinical behavior

American Journal of Surgical Pathology

Volumn 36, Issue 3, 2012, Pages 321-330

  Kraft, Stefan ^a,b   Faquin, William C ^a   Krane, Jeffrey F ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

head and neck cancer; human papillomavirus; neuroendocrine carcinoma; oropharynx; squamous cell carcinoma

Indexed keywords

TUMOR MARKER; VIRUS DNA;

ADULT; AGED; ARTICLE; CARCINOMA; CELL DIFFERENTIATION; CHEMISTRY; FEMALE; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MITOSIS INDEX; OROPHARYNX TUMOR; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SMALL CELL CARCINOMA; SMOKING; SQUAMOUS CELL CARCINOMA; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84857647381     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31823f2f17     Document Type: Article

References (73)

1. Agoff SN, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol. 2000;13:238-242.
2. An HJ, Kim KR, Kim IS, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol. 2005;18:528-534.
3. Andersson S, Rylander E, Larsson B, et al. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer. 2001;37:246-250.
4. Andl T, Kahn T, Pfuhl A, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 1998;58:5-13.
5. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.
6. Barnes L. Neuroendocrine tumours. In: Barnes L, Eveson JW, Reichart P, et al, eds. Head and Neck Tumours. Geneva: WHO Press; 2005:135-139.
7. Batsakis JG, el-Naggar AK, Luna MA. Neuroendocrine tumors of larynx. Ann Otol Rhinol Laryngol. 1992;101:710-714.
8. Bawa R, Wax MK. Small cell carcinoma of the tonsil. Otolaryngol Head Neck Surg. 1995;113:328-333.
9. Begum S, Cao D, Gillison M, et al. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res. 2005;11:5694-5699.
10. Begum S, Gillison ML, Ansari-Lari MA, et al. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res. 2003;9:6469-6475.
11. Begum S, Gillison ML, Nicol TL, et al. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2007;13:1186-1191.
12. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32:1044-1050.
13. Buza N, Cohen PJ, Pei H, et al. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder. Int J Surg Pathol. 2010;18:94-102.
14. Capelli M, Bertino G, Morbini P, et al. Neuroendocrine carcinomas of the upper airways: a small case series with histopathological considerations. Tumori. 2007;93:499-503.
15. Carpenter DH, El-Mofty SK, Lewis JS Jr. Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis. Mod Pathol. 2011;24:1306-1312.
16. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612-619.
17. Chernock RD, Lewis JS Jr Zhang Q, et al. Human papillomaviruspositive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. Hum Pathol. 2010;41:1016-1023.
18. Cohan DM, Popat S, Kaplan SE, et al. Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg. 2009;17:88-94.
19. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-1956.
20. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269.
21. Ferlito A, Silver CE, Bradford CR, et al. Neuroendocrine neoplasms of the larynx: an overview. Head Neck. 2009;31:1634-1646.
22. Fujiwara H, Mitchell MF, Arseneau J, et al. Clear cell adenosquamous carcinoma of the cervix. An aggressive tumor associated with human papillomavirus-18. Cancer. 1995;76:1591-1600.
23. Gillenwater A, Lewin J, Roberts D, et al. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx: a clinically aggressive tumor. Laryngoscope. 2005;115:1191-1195.
24. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407-420.
25. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720.
26. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008;30:898-903.
27. Grayson W, Rhemtula HA, Taylor LF, et al. Detection of human papillomavirus in large cell neuroendocrine carcinoma of the uterine cervix: a study of 12 cases. J Clin Pathol. 2002;55:108-114.
28. Grayson W, Taylor L, Cooper K. Detection of integrated high risk human papillomavirus in adenoid cystic carcinoma of the uterine cervix. J Clin Pathol. 1996;49:805-809.
29. Grayson W, Taylor LF, Cooper K. Carcinosarcoma of the uterine cervix: a report of eight cases with immunohistochemical analysis and evaluation of human papillomavirus status. Am J Surg Pathol. 2001;25:338-347.
30. Hafkamp HC, Manni JJ, Haesevoets A, et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer. 2008;122:2656-2664.
31. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119:2620-2623.
32. Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33:1720-1724.
33. Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology. 2000;36:415-420.
34. Kenny MB, Unger ER, Chenggis ML, et al. In situ hybridization for human papillomavirus DNA in uterine adenosquamous carcinoma with glassy cell features ("glassy cell carcinoma"). Am J Clin Pathol. 1992;98:180-187.
35. Kuo KT, Hsiao CH, Lin CH, et al. The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinomamolecular basis and predicting favorable outcome. Mod Pathol. 2008;21:376-386.
36. Kusafuka K, Asano R, Kamijo T, et al. Large cell neuroendocrine carcinoma of the tongue base: case report of an unusual location with immunohistochemical analysis. Int J Oral Maxillofac Surg. 2009;38:296-299.
37. Lewis JS Jr, Not your usual cancer case: variants of laryngeal squamous cell carcinoma. Head Neck Pathol. 2011;5:23-30.
38. Lewis JS Jr Ferlito A, Gnepp DR, et al. Terminology and classification of neuroendocrine neoplasms of the larynx. Laryngoscope. 2011;121:1187-1193.
39. Lewis JS Jr, Thorstad WL, Chernock RD, et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol. 2010;34:1088-1096.
40. Lo Re G, Canzonieri V, Veronesi A, et al. Extrapulmonary small cell carcinoma: a single-institution experience and review of the literature. Ann Oncol. 1994;5:909-913.
41. Marur S, D'Souza G, Westra WH, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11:781-789.
42. Masand RP, El-Mofty SK, Ma XJ, et al. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011;5:108-116.
43. Matthews-Greer J, Dominguez-Malagon H, Herrera GA, et al. Human papillomavirus typing of rare cervical carcinomas. Arch Pathol Lab Med. 2004;128:553-556.
44. McCluggage WG, Kennedy K, Busam KJ. An immunohistochemical study of cervical neuroendocrine carcinomas: neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am J Surg Pathol. 2010;34:525-532.
45. Mills SE, Cooper PH, Garland TA, et al. Small cell undifferentiated carcinoma of the larynx. Report of two patients and review of 13 additional cases. Cancer. 1983;51:116-120.
46. Mineta H, Miura K, Takebayashi S, et al. Immunohistochemical analysis of small cell carcinoma of the head and neck: a report of four patients and a review of sixteen patients in the literature with ectopic hormone production. Ann Otol Rhinol Laryngol. 2001;110:76-82.
47. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009;125:362-366.
48. Nichols AC, Faquin WC, Westra WH, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009;140:228-234.
49. Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol. 2002;26:1184-1197.
50. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol. 2000;24:1217-1223.
51. Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 2009;4:49-70.
52. Ramqvist T, Dalianis T. Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis. 2010;16:1671-1677.
53. Regauer S, Mannweiler S, Anderhuber W, et al. Cystic lymph node metastases of squamous cell carcinoma of Waldeyer's ring origin. Br J Cancer. 1999;79:1437-1442.
54. Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990;82:1477-1484.
55. Rischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010;28:4142-4148.
56. Serrano MF, El-Mofty SK, Gnepp DR, et al. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck. Hum Pathol. 2008;39:591-598.
57. Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116:2166-2173.
58. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121:2465-2472.
59. Stelow EB, Jo VY, Stoler MH, et al. Human papillomavirus associated squamous cell carcinoma of the upper aerodigestive tract. Am J Surg Pathol. 2010;34:e15-e24.
60. Stoler MH, Mills SE, Gersell DJ, et al. Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol. 1991;15:28-32.
61. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110:1429-1435.
62. Thomison J III Thomas LK, Shroyer KR. Human papillomavirus: molecular and cytologic/histologic aspects related to cervical intraepithelial neoplasia and carcinoma. Hum Pathol. 2008;39:154-166.
63. Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am. 2008;22:1125-1142. vii.
64. Wang BY, Gil J, Kaufman D, et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol. 2002;33:921-926.
65. Weng CT, Chu PY, Liu MT, et al. Small cell carcinoma of the head and neck: a single institution's experience and review of the literature. J Otolaryngol Head Neck Surg. 2008;37:788-793.
66. Wenig BM. Laryngeal neurendocrine carcinomas (LNEC). In: Wenig BM, ed. Atlas of Head and Neck Pathology. Philadelphia: Saunders Elsevier; 2008:503-505.
67. Wenig BM, Hyams VJ, Heffner DK. Moderately differentiated neuroendocrine carcinoma of the larynx. A clinicopathologic study of 54 cases. Cancer. 1988;62:2658-2676.
68. Wu M, Wang B, Gil J, et al. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol. 2003;119:696-702.
69. Yamakawa Y, Forslund O, Teshima H, et al. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol. 1994;53:190-195.
70. Yamamoto R, Hosokawa S, Yamatodani T, et al. Eight cases of neuroendcrine carcinoma of the head and neck. Nihon Jibiinkoka Gakkai Kaiho. 2008;111:517-522.
71. Yuan J, Knorr J, Altmannsberger M, et al. Expression of p16 and lack of pRB in primary small cell lung cancer. J Pathol. 1999;189:358-362.
72. Zhang H, Liu J, Cagle PT, et al. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach. Mod Pathol. 2005;18:111-118.
73. Zhang MQ, El-Mofty SK, Davila RM. Detection of human papillomavirus- related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer. 2008;114:118-123.